SUVRETTA CAPITAL MANAGEMENT, LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$5.9B
Holdings
105
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (105 positions)
| Stock | Value |
|---|---|
ADBEADOBE SYSTEMS INCORPORATED | $365.4B |
AMZNAMAZON COM INC | $325.7B |
MAMASTERCARD INCORPORATED | $294.5B |
UNHUNITEDHEALTH GROUP INC | $279.4B |
RHRH | $223.4B |
OTISOTIS WORLDWIDE CORP | $222.1B |
TPRTAPESTRY INC | $199.1B |
OPENOPENDOOR TECHNOLOGIES INC | $193.9B |
TMOTHERMO FISHER SCIENTIFIC INC | $186.1B |
GFLGFL ENVIRONMENTAL INC | $175.2B |
IQVIQVIA HLDGS INC | $168.4B |
TWLOTWILIO INC | $164.8B |
UNPUNION PAC CORP | $160.7B |
PWRQUANTA SVCS INC | $158.1B |
ELLAUDER ESTEE COS INC | $154.0B |
ABGAMERISOURCEBERGEN CORP | $147.5B |
CVNACARVANA CO | $144.5B |
PLANUSDANAPLAN INC | $131.8B |
ROSTROSS STORES INC | $121.7B |
CPRTCOPART INC | $121.1B |
K6BKBR INC | $117.5B |
MDTMEDTRONIC PLC | $114.2B |
—CANO HEALTH INC | $106.8B |
PTONPELOTON INTERACTIVE INC | $101.6B |
ALITALIGHT INC | $95.9B |
NTRANATERA INC | $83.3B |
TELTE CONNECTIVITY LTD | $82.9B |
ADIANALOG DEVICES INC | $80.0B |
HWMHOWMET AEROSPACE INC | $79.6B |
XYZSQUARE INC | $72.7B |
AGIOAGIOS PHARMACEUTICALS INC | $60.5B |
RPRXROYALTY PHARMA PLC | $55.2B |
FULCFULCRUM THERAPEUTICS INC | $54.8B |
WRBYWARBY PARKER INC | $53.0B |
NXPINXP SEMICONDUCTORS N V | $50.2B |
ITCIEURINTRA-CELLULAR THERAPIES INC | $46.7B |
KURAKURA ONCOLOGY INC | $46.1B |
STROSUTRO BIOPHARMA INC | $42.2B |
ESTCELASTIC N V | $40.4B |
MRTXEURMIRATI THERAPEUTICS INC | $33.8B |
ARNAEURARENA PHARMACEUTICALS INC | $30.2B |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $29.3B |
IM8NINSMED INC | $27.5B |
KALVKALVISTA PHARMACEUTICALS INC | $26.9B |
MRNS*MARINUS PHARMACEUTICALS INC | $25.0B |
MREOMEREO BIOPHARMA GROUP PLC | $22.1B |
—FREYR BATTERY | $20.7B |
EYPTEYEPOINT PHARMACEUTICALS INC | $17.8B |
XENEXENON PHARMACEUTICALS INC | $17.7B |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $17.2B |
—POINT BIOPHARMA GLOBAL INC | $17.1B |
BOLT1EURBOLT BIOTHERAPEUTICS INC | $16.8B |
HRTXHERON THERAPEUTICS INC | $15.9B |
SLDBSOLID BIOSCIENCES INC | $14.3B |
—DICE THERAPEUTICS INC | $13.4B |
290ACHINOOK THERAPEUTICS INC | $13.4B |
OTICEUROTONOMY INC | $13.1B |
KZRKEZAR LIFE SCIENCES INC | $12.2B |
RKLBROCKET LAB USA INC | $12.1B |
AXONEURSIO GENE THERAPIES INC | $11.9B |
CMRXEURCHIMERIX INC | $11.8B |
TERNTERNS PHARMACEUTICALS INC | $11.7B |
—CAZOO GROUP LTD | $11.7B |
INZYINOZYME PHARMA INC | $11.4B |
—PROMETHEUS BIOSCIENCES INC | $11.4B |
—FINSERV ACQUISITION CORP II | $10.6B |
BCABBIOATLA INC | $10.4B |
—GEMINI THERAPEUTICS INC | $8.6B |
IFRXINFLARX NV | $8.5B |
EVLVEVOLV TECHNOLOGIES HLDNGS IN | $8.2B |
CHRSCOHERUS BIOSCIENCES INC | $7.9B |
MOLNMOLECULAR PARTNERS AG | $7.8B |
NRDYNERDY INC | $7.0B |
ACHRARCHER AVIATION INC | $6.7B |
ACIUAC IMMUNE SA | $6.5B |
FRSHFRESHWORKS INC | $6.4B |
IMRXIMMUNEERING CORP | $5.3B |
—NEXIMMUNE INC | $5.2B |
—RESEARCH ALLIANCE CORP II | $4.9B |
MISTMILESTONE PHARMACEUTICALS IN | $4.9B |
—MONTES ARCHIMEDES ACQUISITIO | $4.7B |
NUVLNUVALENT INC | $4.5B |
—FS DEVELOPMENT CORP II | $4.0B |
ORICORIC PHARMACEUTICALS INC | $3.1B |
—HEALTHCOR CATALIO ACQU CORP | $3.0B |
—OMEGA ALPHA SPAC | $2.9B |
—EUROPEAN BIOTECH ACQUTN CORP | $2.9B |
—CANO HEALTH INC | $2.8B |
—BENITEC BIOPHARMA INC | $2.7B |
NEOVVOLTA INC | $2.6B |
—ALIGHT INC | $2.4B |
—DECIBEL THERAPEUTICS INC | $2.0B |
—BCLS ACQUISITION CORP | $2.0B |
—TURMERIC ACQUISITION CORP | $2.0B |
NAUTNAUTILUS BIOTECHNOLOGY INC | $1.9B |
FHTXFOGHORN THERAPEUTICS INC | $1.2B |
—EUCRATES BIOMEDICAL ACQU COR | $978.0M |
—FRAZIER LIFESCIENCES ACQU CO | $859.0M |
ADAGADAGENE INC | $614.0M |
—FINSERV ACQUISITION CORP II | $243.0M |
Page 1 of 2Next